Self-Assembled Nanomicelles as MRI Blood-Pool Contrast Agent
- PMID: 29120077
- DOI: 10.1002/chem.201703962
Self-Assembled Nanomicelles as MRI Blood-Pool Contrast Agent
Abstract
Gadolinium-loaded nanomicelles show promise as future magnetic resonance imaging (MRI) contrast agents (CAs). Their increased size and high gadolinium (Gd) loading gives them an edge in proton relaxivity over smaller molecular Gd-complexes. Their size and stealth properties are fundamental for their long blood residence time, opening the possibility for use as blood-pool contrast agents. Using l-tyrosine as a three-functional scaffold we synthesized a nanostructure building block 8. The double C18 aliphatic chain on one side, Gd-1,4,7,10-tetraazacyclododecane-1-4-7-triacetic acid (Gd-DO3A) with access to bulk water in the center and 2 kDa PEG on the hydrophilic side gave the amphiphilic properties required for the core-shell nanomicellar architecture. The self-assembly into Gd-loaded monodispersed 10-20 nm nanomicelles occurred spontaneously in water. These nanomicelles (Tyr-MRI) display very high relaxivity at 29 mm-1 s-1 at low field strength and low cytotoxicity. Good contrast enhancement of the blood vessels and the heart together with prolonged circulation time in vivo, makes Tyr-MRI an excellent candidate for a new supramolecular blood-pool MRI CA.
Keywords: contrast agent; gadolinium; magnetic resonance imaging; nanomicelles; self-assembly.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
MRI micelles self-assembled from synthetic gadolinium-based nano building blocks.Chem Commun (Camb). 2019 Jan 17;55(7):945-948. doi: 10.1039/c8cc08875f. Chem Commun (Camb). 2019. PMID: 30604781
-
Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.J Drug Target. 2011 Sep;19(8):657-65. doi: 10.3109/1061186X.2010.531727. Epub 2010 Nov 23. J Drug Target. 2011. PMID: 21091273
-
Amphiphilic Nanoaggregates with Bimodal MRI and Optical Properties Exhibiting Magnetic Field Dependent Switching from Positive to Negative Contrast Enhancement.ACS Appl Mater Interfaces. 2019 Feb 13;11(6):5752-5761. doi: 10.1021/acsami.8b18456. Epub 2019 Jan 30. ACS Appl Mater Interfaces. 2019. PMID: 30640430
-
Cyclen-based Gd3+ complexes as MRI contrast agents: Relaxivity enhancement and ligand design.Bioorg Med Chem. 2016 Nov 15;24(22):5663-5684. doi: 10.1016/j.bmc.2016.09.069. Epub 2016 Oct 1. Bioorg Med Chem. 2016. PMID: 27729196 Review.
-
Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.Acc Chem Res. 2009 Jul 21;42(7):822-31. doi: 10.1021/ar800192p. Acc Chem Res. 2009. PMID: 19534516 Review.
Cited by
-
Applications of rare earth elements in cancer: Evidence mapping and scientometric analysis.Front Med (Lausanne). 2022 Aug 10;9:946100. doi: 10.3389/fmed.2022.946100. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36035401 Free PMC article.
-
Cyclodextrins: promising scaffolds for MRI contrast agents.RSC Adv. 2021 Sep 17;11(47):29762-29785. doi: 10.1039/d1ra04084g. eCollection 2021 Sep 1. RSC Adv. 2021. PMID: 35479531 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
